Xequel Bio logo
VerifiedBiotechnology Research

Xequel Bio

Xequel Bio, Inc. is a clinical stage biopharmaceutical company advancing its proprietary aCT1 (alpha-Connexin carboxyl-Terminal 1 peptide) technology platform to develop drugs that will enable physicians to better manage a variety of indications involving inflammation and the body’s response to injury. aCT1 is a patented new chemical entity currently in development for multiple indications. The Company’s lead clinical programs include Granexin® gel in dermatology and iNexinTM ophthalmic solution in ophthalmology. The Company also has ongoing preclinical research in pulmonology.

7-day free trial · no credit card

HeadquartersFort Worth, United StatesEmployees6(11 to 50)Websitexequel.comLinkedIn profileLinkedIn

Verified contacts

6

available on Kipplo

LinkedIn employees

6

11 to 50 range

Open roles

no listings

Distinct roles

6

indexed titles

Tech stack

0

tools in use

Monthly traffic

149

organic / mo

Sign up free to see all 6 verified contacts at Xequel Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

6 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Xequel Bio

6 distinct titles indexed · top 6 shown.

  • 1associate director
  • 1chief commercial & operating officer
  • 1operation lead
  • 1sr director, administration & hr
  • 1vice president research and development
  • 1vice president, research and development

Sign up to unlock all 6 contacts at Xequel Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 6 verified contacts at Xequel Bio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Xequel Bio | Kipplo Discover